By David Feldman at 8 August, 2009, 8:35 am
In a great victory for the reverse merger world and Form 10 shells, as reported in the Reverse Merger Report, Cougar Biotechnology was sold recently to Johnson & Johnson through a tender offer for $1 billion! OK, maybe that doesn’t seem like much compared to Obama’s stimulus package, but it is! Cougar was backed by [...]
Read More >>
Introduction to Reverse Mergers
David N. Feldman is the founder and Managing Partner of Feldman LLP. His practice focuses on corporate and securities matters and general representation of public and private companies, investment banks, private equity firms and high net worth individuals.
David is considered one of the country's leading experts on reverse mergers, in which a private company becomes publicly traded through a merger with a publicly held "shell" company. His book on the subject, Reverse Mergers: Taking a Company Public Without an IPO (Bloomberg Press) was published in 2006, and has since entered its third printing.
